For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are ...

Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, ...

People who stop taking GLP-1 drugs such as Ozempic and Wegovy for weight loss are projected to regain their shed pounds ...

Natco’s escalates the legal battle over semaglutide, one of the world’s most valuable and closely contested pharmaceutical ...

For patients at high cardiovascular risk with overweight or obesity, semaglutide is associated with reduced burden of total ...

Generic drugmakers target a Rs 5000 crore semaglutide opportunity post-patent expiry, facing regulatory challenges in export ...

Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

Treatment with semaglutide has been shown to reduce the total number of hospital admissions and the duration of stays in patients with established cardiovascular disease (CVD) and overweight or ...

GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...

Weight loss and diabetes drugs such as Ozempic and Wegovy may help reduce colon cancer risk, a new study presented at the ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...